Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nitrogen-containing bisphosphonates and lipopolysaccharide mutually augment inflammation via adenosine triphosphate (ATP)-mediated and interleukin 1β (IL-1β)-mediated production of neutrophil extracellular traps (NETs).
Bando K, Kuroishi T, Tada H, Oizumi T, Tanaka Y, Takahashi T, Mizoguchi I, Sugawara S, Endo Y. Bando K, et al. Among authors: oizumi t. J Bone Miner Res. 2021 Sep;36(9):1866-1878. doi: 10.1002/jbmr.4384. Epub 2021 Jun 22. J Bone Miner Res. 2021. PMID: 34075628 Free article.
Augmentation of Lipopolysaccharide-Induced Production of IL-1α and IL-1β in Mice Given Intravenous Zoledronate (a Nitrogen-Containing Bisphosphonate) and Its Prevention by Clodronate (a Non-nitrogen-containing Bisphosphonate).
Suzuki H, Bando K, Tada H, Kiyama T, Oizumi T, Funayama H, Sugawara S, Takahashi T, Endo Y. Suzuki H, et al. Among authors: oizumi t. Biol Pharm Bull. 2019;42(2):164-172. doi: 10.1248/bpb.b18-00408. Biol Pharm Bull. 2019. PMID: 30713248 Free article.
Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
Oizumi T, Yamaguchi K, Funayama H, Kuroishi T, Kawamura H, Sugawara S, Endo Y. Oizumi T, et al. Basic Clin Pharmacol Toxicol. 2009 May;104(5):384-92. doi: 10.1111/j.1742-7843.2008.00374.x. Basic Clin Pharmacol Toxicol. 2009. PMID: 19413658 Free article.
Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.
Yamaguchi K, Oizumi T, Funayama H, Kawamura H, Sugawara S, Endo Y. Yamaguchi K, et al. Among authors: oizumi t. J Oral Maxillofac Surg. 2010 Apr;68(4):889-97. doi: 10.1016/j.joms.2009.04.048. Epub 2010 Jan 6. J Oral Maxillofac Surg. 2010. PMID: 20056305 No abstract available.
Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.
Oizumi T, Funayama H, Yamaguchi K, Yokoyama M, Takahashi H, Yamamoto M, Kuroishi T, Kumamoto H, Sasaki K, Kawamura H, Sugawara S, Endo Y. Oizumi T, et al. J Oral Maxillofac Surg. 2010 May;68(5):1043-54. doi: 10.1016/j.joms.2009.08.027. Epub 2010 Feb 13. J Oral Maxillofac Surg. 2010. PMID: 20156665
145 results